Literature DB >> 19950011

Activation of γδ T cells by bisphosphonates.

Keith Thompson1, Anke J Roelofs, Marjo Jauhiainen, Hannu Mönkkönen, Jukka Mönkkönen, Michael J Rogers.   

Abstract

After decades of successful clinical use, the exact molecular mechanisms by which the anti-resorptive bisphosphonate drugs (BPs) exert their effects are now being revealed. In addition to their anti-resorptive effects, it is now apparent that nitrogen-containing BPs (N-BPs) have immunomodulatory properties. Specifically, these drugs activate immune cells called gamma, delta T lymphocytes. In this chapter we discuss the mechanism of gamma, delta T cell activation by N-BPs and propose that N-BPs may provide a safe and effective means for manipulating gamma,delta T cell activity in future immunotherapeutic approaches.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 19950011     DOI: 10.1007/978-1-4419-1050-9_2

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


  24 in total

1.  Bisphosphonates target B cells to enhance humoral immune responses.

Authors:  Elena Tonti; Nereida Jiménez de Oya; Gabriele Galliverti; E Ashley Moseman; Pietro Di Lucia; Angelo Amabile; Stefano Sammicheli; Marco De Giovanni; Laura Sironi; Nicolas Chevrier; Giovanni Sitia; Luigi Gennari; Luca G Guidotti; Ulrich H von Andrian; Matteo Iannacone
Journal:  Cell Rep       Date:  2013-10-10       Impact factor: 9.423

2.  Cutting edge: nitrogen bisphosphonate-induced inflammation is dependent upon mast cells and IL-1.

Authors:  John T Norton; Tomoko Hayashi; Brian Crain; John S Cho; Lloyd S Miller; Maripat Corr; Dennis A Carson
Journal:  J Immunol       Date:  2012-03-02       Impact factor: 5.422

3.  Increased CD14+ and decreased CD14- populations of monocytes 48 h after zolendronic acid infusion in breast cancer patients.

Authors:  A Kyrgidis; M P Yavropoulou; R Lagoudaki; C Andreadis; K Antoniades; D Kouvelas
Journal:  Osteoporos Int       Date:  2016-11-17       Impact factor: 4.507

4.  γδ T cells attenuate bleomycin-induced fibrosis through the production of CXCL10.

Authors:  Derek A Pociask; Kong Chen; Sun Mi Choi; Tim D Oury; Chad Steele; Jay K Kolls
Journal:  Am J Pathol       Date:  2011-03       Impact factor: 4.307

Review 5.  γδ T cell receptor ligands and modes of antigen recognition.

Authors:  Eric Champagne
Journal:  Arch Immunol Ther Exp (Warsz)       Date:  2011-02-06       Impact factor: 4.291

6.  Role of IL-1 receptor-associated kinase-M (IRAK-M) in priming of immune and inflammatory responses by nitrogen bisphosphonates.

Authors:  John T Norton; Tomoko Hayashi; Brian Crain; Maripat Corr; Dennis A Carson
Journal:  Proc Natl Acad Sci U S A       Date:  2011-06-20       Impact factor: 11.205

7.  Analysis of Immune Cells from Human Mammary Ductal Epithelial Organoids Reveals Vδ2+ T Cells That Efficiently Target Breast Carcinoma Cells in the Presence of Bisphosphonate.

Authors:  Nicholas A Zumwalde; Jill D Haag; Deepak Sharma; Jennifer A Mirrielees; Lee G Wilke; Michael N Gould; Jenny E Gumperz
Journal:  Cancer Prev Res (Phila)       Date:  2016-01-25

Review 8.  Anti-tumour activity of bisphosphonates in preclinical models of breast cancer.

Authors:  Ingunn Holen; Robert E Coleman
Journal:  Breast Cancer Res       Date:  2010-12-16       Impact factor: 6.466

9.  The facial skeleton in patients with osteoporosis: a field for disease signs and treatment complications.

Authors:  Athanassios Kyrgidis; Thrasivoulos-George Tzellos; Konstantinos Toulis; Konstantinos Antoniades
Journal:  J Osteoporos       Date:  2011-02-16

10.  Human γδ T lymphocytes for immunotherapeutic strategies against cancer.

Authors:  Dieter Kabelitz
Journal:  F1000 Med Rep       Date:  2010-06-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.